Core Points - Regentis Biomaterials Ltd. has announced the pricing of its initial public offering (IPO) of 1,250,000 ordinary shares at $8.00 per share, aiming for gross proceeds of $10 million before expenses [1][3] - The ordinary shares are set to begin trading on the NYSE American under the symbol "RGNT" on December 4, 2025, with the offering expected to close around December 5, 2025 [2] - The company plans to utilize the net proceeds primarily for development activities, including completing its pivotal trial and preparing for PMA submission for its product GerlinC, as well as for corporate purposes such as debt repayment [3] Company Overview - Regentis Biomaterials Ltd. focuses on regenerative medicine, specifically developing innovative tissue repair solutions to enhance patient health and quality of life [6] - The company's lead product, GelrinC, is a cell-free hydrogel designed for treating articular knee cartilage injuries and has received CE mark approval in Europe [6] - Regentis aims to commercialize GelrinC in Europe while also working towards obtaining FDA approval in the United States [6]

Group 1 - The U.S. IPO market saw two small IPOs and three SPACs listed last week, with five IPOs and four SPACs filing initial applications [1][2] - Off The Hook YS (OTH) priced its reduced IPO at the lower end of the range, raising $15 million with a market cap of $95 million, but its stock fell by 8% [1] - Phaos Technology (POAS) also priced its IPO at the lower end, raising $14 million with a market cap of $114 million, and its stock remained flat [1] Group 2 - Three SPACs completed pricing last week: Alussa Energy Acquisition II (ALUB.U) raised $250 million targeting energy and power infrastructure, Evolution Global Acquisition (EVOXU) raised $210 million focusing on critical minerals, and Blueport Acquisition (BPACU) raised $50 million [2] - Five companies filed for IPOs last week, including Klook (KLK) seeking $400 million, Grayscale (GRAY) aiming for $100 million, and Reed's (REED) targeting $10 million [2][4] Group 3 - Upcoming IPOs include Central Bancompany (CBC) planning to raise $400 million with a market cap of $5.365 billion, and Gloo Holdings (GLOO) aiming for $100 million with a market cap of $801 million [5][7] - Regentis Biomaterials (RGNT) plans to raise $11 million with a market cap of $62 million, focusing on a hydrogel implant for knee cartilage pain [6][7]

Summary of Key Points Core Viewpoint - The article discusses recent IPO activities, highlighting six new stocks that raised approximately $540 million, along with upcoming IPO plans for four companies in the near future [1]. Group 1: Recent IPOs - Six new stocks were listed last week, raising about $540 million in total [1]. - Off The Hook (OTH) raised $15 million by issuing 3.75 million shares at $4 each, down from an initial plan of 5 million shares [1]. - Phaos Technology (POAS) raised $14.4 million by issuing 3.6 million shares at $4 each [1]. - Caring Brands (CABR) raised $4 million by issuing 1 million shares at $4 each [1]. - SPAC Evolution Global Acquisition (EVOXU) raised $210 million, Blueport Acquisition (BPACU) raised $50 million, and Alussa Energy Acquisition II (ALUBU) raised $250 million [1]. - Twelve companies submitted IPO applications, including five from China, with four being blank check companies [1]. Group 2: Upcoming IPOs - Gloo Holdings, Inc. plans to go public on November 19, 2025, on NASDAQ under the ticker GLOO, aiming to raise approximately $109 million by issuing 9.1 million shares at $10 to $12 each [3][4]. - Regentis Biomaterials Ltd. plans to list on NYSE MKT on November 19, 2025, under the ticker RGNT, seeking to raise about $12 million by issuing 1 million shares at $10 to $12 each [5][6]. - Central Bancompany, Inc. plans to go public on November 20, 2025, on NASDAQ under the ticker CBC, aiming to raise approximately $427 million by issuing 17.78 million shares at $21 to $24 each, with reported revenue of $735 million and net profit of $283 million for the nine months ending September 30, 2025 [7][8]. - Libera Gaming Operations, Inc. plans to list on NASDAQ on November 21, 2025, under the ticker LBRJ, aiming to raise about $7.5 million by issuing 1.25 million shares at $4 to $6 each, with revenue of $52.52 million and net profit of $4.16 million for the twelve months ending October 31, 2024 [9][10].